Qube Research & Technologies LTD Cardiovascular Systems Inc Transaction History

Qube Research & Technologies LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$13.31 - $19.86 $5.61 Million - $8.38 Million	421,755 Added 2627.92%	437,804 $8.69 Million
Q4 2022 Feb 14, 2023	BUY	$12.74 - $15.12 $204,464 - $242,660	16,049 New	16,049 $218,000
Q2 2022 Aug 15, 2022	BUY	$13.53 - $23.34 $711,786 - $1.23 Million	52,608 New	52,608 $755,000
Q1 2022 May 09, 2022	SELL	$16.14 - $22.6 $678,444 - $949,991	-42,035 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$18.64 - $36.77 $783,532 - $1.55 Million	42,035 New	42,035 $789,000
Q2 2021 Aug 13, 2021	SELL	$34.41 - $44.03 $228,757 - $292,711	-6,648 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$37.29 - $47.19 $247,903 - $313,719	6,648 New	6,648 $255,000
Q3 2020 Nov 12, 2020	SELL	$27.86 - $39.35 $242,354 - $342,305	-8,699 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$30.3 - $42.55 $85,021 - $119,395	2,806 Added 47.62%	8,699 $274,000
Q1 2020 May 15, 2020	BUY	$30.0 - $54.18 $29,040 - $52,446	968 Added 19.65%	5,893 $207,000
Q4 2019 Feb 13, 2020	BUY	$42.29 - $52.2 $208,278 - $257,085	4,925 New	4,925 $239,000

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.